Haemonetics (HAE) Invested Capital (2010 - 2026)

Haemonetics' Invested Capital history runs 17 years deep, the most recent figure standing at $2.0 billion for Q1 2026.

• In Q1 2026, Invested Capital changed 0.46% year-over-year to $2.0 billion; the TTM figure through Mar 2026 stood at $2.0 billion (changed 0.46% YoY), while the FY2026 annual figure was $2.0 billion, changed 0.46% from the prior year.
• Invested Capital was $2.0 billion for Q1 2026 at Haemonetics, down from $2.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $2.1 billion in Q4 2025 to a low of $730.8 million in Q1 2022.
• Historically, Invested Capital has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Invested Capital decreased 29.03% in 2022, then surged 135.73% in 2025.
• A 5-year view of Invested Capital shows it stood at $1.3 billion in 2022, then decreased by 4.59% to $1.2 billion in 2023, then declined by 25.01% to $906.9 million in 2024, then surged by 135.56% to $2.1 billion in 2025, then fell by 4.68% to $2.0 billion in 2026.
• The last three Invested Capital figures came in at $2.0 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.